Front-line Chemo-immunotherapy with Nivolumab and Dose-Adjusted EPOCH in Peripheral T-cell Lymphoma: A Phase I Trial.
Bradley M HaverkosJasmine M ZainManali KamdarAlexander NeuweltEduardo DavilaXander BradeenAjay MajorSteven M BairJagar JasemClayton SmithDiana AbbottPierluigi PorcuPublished in: Blood advances (2023)